Highlights Boston Scientific Corporation

Equities

BSX

US1011371077

Advanced Medical Equipment & Technology

Real-time Estimate Cboe BZX Other stock markets 20:43:54 15/12/2025 GMT			5-day change	1st Jan Change
91.97 ^USD	-0.66%		-2.04%	+2.92%

12-08	Why the Fed's Next Move Matters More Than Markets Admit
12-08	Analyst recommendations: 3M Company, Exxon Mobil, Mastercard, Netflix, Tesla…

Highlights

Boston Scientific Corporation acquired 400,000-SQFT property at 1 Boston Scientific Way from Ryan Cos. for approximately $190 million.	12-07	CI
Medtronic raises annual sales growth forecast on heart devices demand	11-18	RE
Worldwide Healthcare improves in first-half; sees lower final dividend	11-13	AN
Elutia Q3 revenue falls short of estimates, gross margin improves	11-06	RE
Tranche Update on Boston Scientific Corporation's Equity Buyback Plan announced on December 14, 2020.	11-03	CI
Boston Scientific Insider Sold Shares Worth $1,306,900, According to a Recent SEC Filing	10-28	MT
Boston Scientific Lifts Full-Year Outlook as Third-Quarter Results Top Views	10-22	MT
Boston Scientific Shares Rise After Q3 Results Top Estimates, 2025 Outlook Lifted	10-22	MT
Sector Update: Health Care Stocks Mixed Premarket Wednesday	10-22	MT
Boston Scientific Corporation Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025	10-22	CI
Stocks Down Pre-Bell as Trump Signals Xi Jinping Meeting May Not Happen; Tesla Earnings on Deck	10-22	MT
Boston Scientific lifts annual profit forecast on strong demand for heart devices	10-22	RE
Boston Scientific Announces Earnings Guidance for the Fourth Quarter and Full Year 2025	10-22	CI
Boston Scientific Q3 Adjusted Earnings, Sales Increase; 2025 Outlook Lifted; Q4 Guidance Issued	10-22	MT
Boston Scientific Raises Outlook on Continued Cardiovascular Growth	10-22	DJ
(BSX) Boston Scientific Corporation Expects Q4 Adjusted EPS Range $0.77 - $0.79	10-22	MT
Medical device maker Boston Scientific beats Q3 revenue estimates on strong US demand	10-22	RE
Earnings Flash (BSX) Boston Scientific Corporation Reports Q3 Revenue $5.07B, vs. FactSet Est of $4.97B	10-22	MT
Earnings Flash (BSX) Boston Scientific Corporation Posts Q3 Adjusted EPS $0.75 per Share, vs. FactSet Est of $0.71	10-22	MT
(BSX) Boston Scientific Expects 2025 Adjusted EPS Range $3.02 to $3.04, vs. FactSet Est of $2.97	10-22	MT
Boston Scientific Corporation agreed to acquire remaining stake in Nalu Medical, Inc. for approximately $530 million.	10-17	CI
When the List of Worries Starts to Pile Up	10-17
Boston Scientific boosts chronic pain therapy portfolio with Nalu deal	10-17	RE
Boston Scientific to Buy Rest of Nalu Medical for $533 Million	10-17	DJ
Boston Scientific to Acquire Remaining Shares of Nalu Medical for $533 Million	10-17	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Headlines

Boston Scientific exceeds analysts' estimates for seven straight quarters

June 26, 2025 at 10:04 am